Christopher Macdonell Coley, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia | 20 | 2002 | 2140 | 0.390 |
Why?
|
| Community-Acquired Infections | 19 | 2002 | 468 | 0.390 |
Why?
|
| Medication Systems, Hospital | 5 | 2008 | 154 | 0.330 |
Why?
|
| Prostate-Specific Antigen | 8 | 2001 | 2469 | 0.300 |
Why?
|
| Medical Order Entry Systems | 5 | 2017 | 521 | 0.270 |
Why?
|
| Students | 4 | 2007 | 1741 | 0.250 |
Why?
|
| Medication Errors | 6 | 2010 | 783 | 0.230 |
Why?
|
| Physical Examination | 4 | 2001 | 1254 | 0.210 |
Why?
|
| Musculoskeletal Diseases | 4 | 2007 | 597 | 0.210 |
Why?
|
| Computers | 2 | 2004 | 596 | 0.200 |
Why?
|
| Medical Records Systems, Computerized | 4 | 2009 | 1192 | 0.180 |
Why?
|
| Arm Injuries | 1 | 2000 | 156 | 0.160 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2000 | 151 | 0.160 |
Why?
|
| Arm | 1 | 2002 | 590 | 0.160 |
Why?
|
| Thallium Radioisotopes | 4 | 1992 | 138 | 0.150 |
Why?
|
| Dipyridamole | 4 | 1992 | 140 | 0.150 |
Why?
|
| Severity of Illness Index | 12 | 2011 | 15835 | 0.140 |
Why?
|
| Preoperative Care | 5 | 1996 | 2242 | 0.130 |
Why?
|
| Prostatic Neoplasms | 8 | 2001 | 11116 | 0.120 |
Why?
|
| Decision Support Systems, Clinical | 4 | 2017 | 1175 | 0.110 |
Why?
|
| Videotape Recording | 1 | 2015 | 337 | 0.110 |
Why?
|
| Ambulatory Care | 5 | 1998 | 2775 | 0.100 |
Why?
|
| Intraoperative Care | 1 | 1996 | 766 | 0.100 |
Why?
|
| Clinical Pharmacy Information Systems | 2 | 2009 | 102 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 787 | 0.100 |
Why?
|
| Athletic Injuries | 1 | 2000 | 1216 | 0.090 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2011 | 73 | 0.090 |
Why?
|
| Medication Reconciliation | 1 | 2010 | 153 | 0.080 |
Why?
|
| Mass Screening | 4 | 1997 | 5428 | 0.070 |
Why?
|
| Decision Making | 3 | 2015 | 3929 | 0.070 |
Why?
|
| Patient Preference | 1 | 2015 | 926 | 0.070 |
Why?
|
| Coronary Disease | 5 | 1994 | 5919 | 0.070 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2015 | 992 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 2015 | 1329 | 0.070 |
Why?
|
| Medical Audit | 1 | 2008 | 453 | 0.070 |
Why?
|
| User-Computer Interface | 3 | 2010 | 1399 | 0.070 |
Why?
|
| Resuscitation Orders | 2 | 2015 | 270 | 0.070 |
Why?
|
| Anesthesia, Conduction | 1 | 2010 | 262 | 0.070 |
Why?
|
| Dermatomyositis | 1 | 2009 | 259 | 0.070 |
Why?
|
| Forms and Records Control | 1 | 2007 | 158 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 2110 | 0.060 |
Why?
|
| Pain | 1 | 2000 | 5077 | 0.060 |
Why?
|
| Medicare | 4 | 1995 | 6758 | 0.060 |
Why?
|
| Observation | 1 | 2007 | 310 | 0.060 |
Why?
|
| Probability | 4 | 2002 | 2478 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 1996 | 1923 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2008 | 773 | 0.060 |
Why?
|
| Rectum | 3 | 2001 | 892 | 0.060 |
Why?
|
| Hospitalization | 5 | 2005 | 10715 | 0.060 |
Why?
|
| Continuity of Patient Care | 2 | 2008 | 1069 | 0.060 |
Why?
|
| Inpatients | 1 | 2015 | 2548 | 0.050 |
Why?
|
| Likelihood Functions | 2 | 1997 | 991 | 0.050 |
Why?
|
| Nova Scotia | 5 | 2000 | 34 | 0.050 |
Why?
|
| Length of Stay | 4 | 2000 | 6422 | 0.050 |
Why?
|
| Critical Illness | 1 | 2015 | 2722 | 0.050 |
Why?
|
| Biopsy, Needle | 2 | 1997 | 1626 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 1303 | 0.040 |
Why?
|
| Male | 39 | 2015 | 360621 | 0.040 |
Why?
|
| Patient Admission | 4 | 2008 | 1367 | 0.040 |
Why?
|
| Anesthesiology | 1 | 2010 | 1117 | 0.040 |
Why?
|
| Aged | 30 | 2015 | 169179 | 0.040 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2000 | 131 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2002 | 2281 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 2001 | 1975 | 0.040 |
Why?
|
| Middle Aged | 31 | 2015 | 220774 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 3 | 2010 | 7389 | 0.040 |
Why?
|
| Humans | 53 | 2017 | 761326 | 0.040 |
Why?
|
| Risk Factors | 16 | 2007 | 74152 | 0.040 |
Why?
|
| Age Distribution | 3 | 2002 | 2880 | 0.040 |
Why?
|
| Pennsylvania | 4 | 2000 | 613 | 0.040 |
Why?
|
| Prospective Studies | 15 | 2015 | 54405 | 0.040 |
Why?
|
| Age Factors | 7 | 2001 | 18401 | 0.030 |
Why?
|
| Laboratories, Hospital | 1 | 2017 | 193 | 0.030 |
Why?
|
| Female | 31 | 2015 | 392485 | 0.030 |
Why?
|
| Prevalence | 4 | 2000 | 15719 | 0.030 |
Why?
|
| Predictive Value of Tests | 6 | 2002 | 15262 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2000 | 948 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 3889 | 0.030 |
Why?
|
| Patient Discharge | 3 | 2008 | 3438 | 0.030 |
Why?
|
| Logistic Models | 3 | 2000 | 13251 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 415 | 0.030 |
Why?
|
| Adult | 23 | 2004 | 221122 | 0.030 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 2760 | 0.030 |
Why?
|
| Reimbursement Mechanisms | 2 | 1995 | 665 | 0.030 |
Why?
|
| Prostatic Hyperplasia | 1 | 1997 | 521 | 0.030 |
Why?
|
| Models, Economic | 1 | 1997 | 716 | 0.030 |
Why?
|
| Neoplasm Staging | 4 | 2001 | 11098 | 0.030 |
Why?
|
| Risk | 7 | 2002 | 9605 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6231 | 0.020 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 1995 | 385 | 0.020 |
Why?
|
| Reference Standards | 1 | 1995 | 1004 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 1994 | 626 | 0.020 |
Why?
|
| United States | 9 | 2002 | 72317 | 0.020 |
Why?
|
| Cause of Death | 1 | 2002 | 3685 | 0.020 |
Why?
|
| Treatment Outcome | 9 | 2011 | 64645 | 0.020 |
Why?
|
| Algorithms | 5 | 2001 | 14025 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 2 | 1990 | 1490 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2000 | 9639 | 0.020 |
Why?
|
| Deoxycholic Acid | 1 | 1990 | 53 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2009 | 20092 | 0.020 |
Why?
|
| Ursodeoxycholic Acid | 1 | 1990 | 81 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 984 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 4 | 1997 | 5492 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 941 | 0.020 |
Why?
|
| Cohort Studies | 8 | 2011 | 41440 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 1996 | 1165 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2002 | 3744 | 0.020 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2010 | 197 | 0.020 |
Why?
|
| Cholelithiasis | 1 | 1990 | 407 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1990 | 407 | 0.020 |
Why?
|
| Aged, 80 and over | 7 | 2015 | 58946 | 0.020 |
Why?
|
| Comorbidity | 5 | 2002 | 10498 | 0.020 |
Why?
|
| Prostate | 1 | 1995 | 1770 | 0.020 |
Why?
|
| Program Evaluation | 1 | 1995 | 2494 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 1997 | 1998 | 0.020 |
Why?
|
| Linear Models | 2 | 2010 | 5871 | 0.020 |
Why?
|
| Software Design | 1 | 2006 | 171 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 1996 | 15647 | 0.020 |
Why?
|
| Hospitals, University | 2 | 1998 | 564 | 0.020 |
Why?
|
| Multivariate Analysis | 4 | 2002 | 12059 | 0.020 |
Why?
|
| Texas | 1 | 2007 | 405 | 0.020 |
Why?
|
| Life Expectancy | 3 | 2001 | 1242 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 3 | 2000 | 7439 | 0.020 |
Why?
|
| Anesthesia | 1 | 1996 | 1592 | 0.020 |
Why?
|
| Efficiency | 1 | 2008 | 476 | 0.020 |
Why?
|
| Hospital Information Systems | 1 | 2007 | 394 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 2008 | 601 | 0.010 |
Why?
|
| Organizational Innovation | 1 | 2006 | 536 | 0.010 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 14665 | 0.010 |
Why?
|
| Radiography | 3 | 2001 | 6966 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1996 | 11454 | 0.010 |
Why?
|
| Nerve Block | 1 | 2010 | 705 | 0.010 |
Why?
|
| Societies, Medical | 2 | 2010 | 3905 | 0.010 |
Why?
|
| Risk Assessment | 3 | 2002 | 23981 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2009 | 1836 | 0.010 |
Why?
|
| Boston | 3 | 2000 | 9333 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 5970 | 0.010 |
Why?
|
| ROC Curve | 2 | 2002 | 3572 | 0.010 |
Why?
|
| Universities | 1 | 2007 | 994 | 0.010 |
Why?
|
| Utilization Review | 1 | 2002 | 382 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2001 | 379 | 0.010 |
Why?
|
| Quality of Life | 3 | 2011 | 13355 | 0.010 |
Why?
|
| Prostatectomy | 2 | 2001 | 1824 | 0.010 |
Why?
|
| Diabetes Mellitus | 2 | 1989 | 5841 | 0.010 |
Why?
|
| Cryotherapy | 1 | 2001 | 159 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 2170 | 0.010 |
Why?
|
| Data Collection | 1 | 2008 | 3324 | 0.010 |
Why?
|
| Upper Extremity | 1 | 2004 | 657 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2002 | 10075 | 0.010 |
Why?
|
| Health Services | 1 | 2004 | 752 | 0.010 |
Why?
|
| Oximetry | 1 | 2001 | 460 | 0.010 |
Why?
|
| Lung | 1 | 1996 | 9994 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 2751 | 0.010 |
Why?
|
| Erythromycin | 1 | 1997 | 117 | 0.010 |
Why?
|
| Immunocompetence | 1 | 1997 | 138 | 0.010 |
Why?
|
| Canada | 1 | 2002 | 2120 | 0.010 |
Why?
|
| Pelvis | 1 | 2001 | 732 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2002 | 2426 | 0.010 |
Why?
|
| Cost Savings | 1 | 2000 | 913 | 0.010 |
Why?
|
| Proportional Hazards Models | 2 | 2002 | 12450 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2000 | 731 | 0.010 |
Why?
|
| Hospital Mortality | 2 | 2002 | 5291 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2001 | 1273 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1989 | 6389 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2010 | 4813 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2007 | 26108 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2004 | 1935 | 0.010 |
Why?
|
| Pneumonia, Bacterial | 1 | 1996 | 316 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2000 | 12972 | 0.010 |
Why?
|
| Bacteremia | 1 | 2000 | 979 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1996 | 342 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 1998 | 1156 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 8632 | 0.010 |
Why?
|
| Time Factors | 3 | 2002 | 39974 | 0.010 |
Why?
|
| Software | 1 | 2007 | 4439 | 0.010 |
Why?
|
| Retrospective Studies | 5 | 2007 | 80575 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2001 | 39108 | 0.010 |
Why?
|
| Recurrence | 2 | 1998 | 8470 | 0.010 |
Why?
|
| Survival Rate | 2 | 1996 | 12710 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1998 | 2642 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1997 | 2853 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1995 | 8526 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2001 | 6815 | 0.010 |
Why?
|
| Cryosurgery | 1 | 1995 | 474 | 0.010 |
Why?
|
| Prognosis | 3 | 1997 | 29588 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2001 | 2568 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 4908 | 0.010 |
Why?
|
| Glycosuria | 1 | 1989 | 44 | 0.010 |
Why?
|
| Outpatients | 1 | 1997 | 1596 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1990 | 642 | 0.000 |
Why?
|
| Biopsy | 1 | 2001 | 6768 | 0.000 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1991 | 578 | 0.000 |
Why?
|
| Radiotherapy | 1 | 1995 | 1499 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 2002 | 7824 | 0.000 |
Why?
|
| Electrocardiography | 2 | 1991 | 6382 | 0.000 |
Why?
|
| Pregnancy in Diabetics | 1 | 1988 | 197 | 0.000 |
Why?
|
| Adolescent | 3 | 2002 | 88305 | 0.000 |
Why?
|
| Glucose Tolerance Test | 1 | 1989 | 1178 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1995 | 6341 | 0.000 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 1989 | 467 | 0.000 |
Why?
|
| Angina Pectoris | 1 | 1989 | 959 | 0.000 |
Why?
|
| Massachusetts | 1 | 1998 | 8837 | 0.000 |
Why?
|
| Health Status | 1 | 1997 | 4075 | 0.000 |
Why?
|
| Incidence | 1 | 2002 | 21336 | 0.000 |
Why?
|
| Exercise Test | 1 | 1991 | 2129 | 0.000 |
Why?
|
| Patient Readmission | 1 | 1998 | 3267 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1995 | 3577 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2001 | 9275 | 0.000 |
Why?
|
| Diabetes Complications | 1 | 1989 | 1317 | 0.000 |
Why?
|
| Coronary Angiography | 1 | 1991 | 4472 | 0.000 |
Why?
|
| Health Services Accessibility | 1 | 1997 | 5439 | 0.000 |
Why?
|
| Acute Disease | 1 | 1990 | 7238 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1989 | 2246 | 0.000 |
Why?
|
| Pneumonia, Viral | 1 | 1996 | 3200 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1995 | 10203 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 20555 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1988 | 3441 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2001 | 36430 | 0.000 |
Why?
|
| Heart Failure | 1 | 1996 | 11672 | 0.000 |
Why?
|
| Pregnancy | 1 | 1988 | 29858 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1988 | 12144 | 0.000 |
Why?
|